Lupin, a leading pharmaceutical company, recently released its quarterly report for the third quarter of fiscal year 2023-24 (Q3FY24). The report unveiled remarkable figures, withView More
PATHFINDERS TRAININGS
unlocking your potential
Lupin, a leading pharmaceutical company, recently released its quarterly report for the third quarter of fiscal year 2023-24 (Q3FY24). The report unveiled remarkable figures, withView More